Trial Runners is preparing to hit the road for Conference season this year. The field of ophthalmology offers multipile options for industry thought leaders and presenters to network and share ideas in a forum setting.
The Clinical Trial Innovation Summit in Boston, MA will be an opportunity for Trial Runners to announce and unveil their new brad: Orphanos. Orphanos is their rare disease and orphan drugs CRO and is already gearing up for a busy year as well.
Trial Runners has been a sponsor and participant in the OIS program for the past two years and continue to show unbridled, enthiusiastic support for the people at OIS and Healthegy, organizers of the event that aligns with ASCRS. This year's OIS@ASCRS is taking place in Los Angeles.
Per tradition, Trial Runners will be an active participant in ARVO taking place in Baltimore, MD this year. ARVO is shaping up to be as big and bustling as ever before and Trial Runners is looking forward to treating its booth visitors with all sorts of fun activities.
Trial Runners is hopping across the ocean to attend the vastly popular Euretina Congress this year in Barcelona. The retina, albeit such a small area of the human body, garners enough focus to justify thousands of individuals across the globe to convene and network in the ophthalmology industry.
Later in the month of September Trial Runners will be attending Healthtech's Targeting Ocular Disorders program of Discovery on Target, the industry's preeminent event on novel drug targets. This is a new venture for the company and last year's visit proved to be very beneficial so they are coming back this year.
To wrap up the year Trial Runners will be going back to New Orleans to attend the OIS event at AAO. This experience was very advantageous for the company last year and Trial Runners is looking forward to whatever participation opportunities the people at Healthegy and OIS have planned for this summit.